Polymer Capital Management (HK) LTD
Position in CRVS — Corvus Pharmaceuticals, Inc.
CIK 1970465
HONG KONG, K3
Position in CRVS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$2,680,025
New position
Shares Held
183,187
first reported quarter
Ownership
0.218%
of shares outstanding
% of Portfolio
0.41%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Polymer Capital Management (HK) LTD holds $45,624,600 across 11 Biotechnology names. CRVS ranks #5 (5.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
57,784 | $19,118,992 | |
| 2 | ERAS |
Erasca, Inc.
|
357,670 | $5,787,100 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
61,200 | $4,595,508 | |
| 4 | AVBP |
ArriVent BioPharma, Inc.
|
122,276 | $2,820,907 | |
| 5 | CRVS |
Corvus Pharmaceuticals, Inc.
This page
|
183,187 | $2,680,025 | |
| 6 | MANE |
Veradermics, Inc
|
41,296 | $2,607,842 | |
| 7 | SMMT |
Summit Therapeutics Inc.
|
133,034 | $2,522,324 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
23,227 | $2,258,825 |
All Filings in CRVS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,680,025 | 183,187 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||